Algert Global LLC Corcept Therapeutics Inc Transaction History

Algert Global LLC

$3.72 Billion
Q3 2024

A detailed history of Algert Global LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Algert Global LLC holds 40,115 shares of CORT stock, worth $2.73 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

40,115

Previous 12,685 216.24%

Holding current value

$2.73 Million

Previous $412,000 350.73%

% of portfolio

0.05%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$29.51 - $46.26 $809,459 - $1.27 Million	27,430 Added 216.24%	40,115 $1.86 Million
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $281,733 - $437,378	12,685 New	12,685 $412,000
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $842,887 - $1.12 Million	33,960 Added 38.52%	122,120 $3.97 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $119,648 - $184,074	5,446 Added 6.58%	88,160 $2.4 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $1.41 Million - $1.65 Million	65,610 Added 383.59%	82,714 $1.84 Million
Q1 2023 May 12, 2023	SELL	$19.2 - $24.47 $1.64 Million - $2.09 Million	-85,520 Reduced 83.33%	17,104 $370,000
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $58,054 - $87,183	2,910 Added 2.92%	102,624 $2.08 Million
Q3 2022 Nov 15, 2022	BUY	$24.7 - $29.12 $172,653 - $203,548	6,990 Added 7.54%	99,714 $2.56 Million
Q2 2022 Aug 15, 2022	BUY	$17.33 - $25.3 $398,832 - $582,254	23,014 Added 33.01%	92,724 $2.21 Million
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $740,378 - $1.13 Million	44,790 Added 179.74%	69,710 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $426,132 - $581,632	24,920 New	24,920 $493,000

Others Institutions Holding CORT

# of Institutions

361

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.28B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Corcept Therapeutics Inc Transaction History